Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srividya Sundararaman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Immunology, Immunotherapy : CII|April 25, 2016
How frequently are predicted peptides actually recognized by CD8 cells?Ioana Moldovan, Oleg Targoni, Wenji Zhang, et al.
Cells|January 14, 2015
Serial Measurements of Apoptotic Cell Numbers Provide Better Acceptance Criterion for PBMC Quality than a Single Measurement Prior to the T Cell AssayMarie Wunsch, Richard Caspell, Stefanie Kuerten, et al.
Cells|February 3, 2015
ELISPOT Assays in 384-Well Format: Up to 30 Data Points with One Million CellsJodi Hanson, Srividya Sundararaman, Richard Caspell, et al.
Cells|December 8, 2017
A Positive Control for Detection of Functional CD4 T Cells in PBMC: The CPI PoolAnnemarie Schiller, Ting Zhang, Ruliang Li, et al.
Cells|January 23, 2015
ELISPOTs Produced by CD8 and CD4 Cells Follow Log Normal Size Distribution Permitting Objective CountingAlexey Y Karulin, Kinga Karacsony, Wenji Zhang, et al.
Viruses|August 11, 2015
Characterization of the HCMV-Specific CD4 T Cell Responses that Are Associated with Protective ImmunityMarie Wunsch, Wenji Zhang, Jodi Hanson, et al.
Cells|April 27, 2018
High-Throughput GLP-Capable Target Cell Visualization Assay for Measuring Cell-Mediated CytotoxicityAnna Welter, Srividya Sundararaman, Ruliang Li, et al.
Cells|January 14, 2015
High Reproducibility of ELISPOT Counts from Nine Different LaboratoriesSrividya Sundararaman, Alexey Y Karulin, Tameem Ansari, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|April 25, 2016
How frequently are predicted peptides actually recognized by CD8 cells?Ioana Moldovan, Oleg Targoni, Wenji Zhang, et al.
Cells|January 14, 2015
Serial Measurements of Apoptotic Cell Numbers Provide Better Acceptance Criterion for PBMC Quality than a Single Measurement Prior to the T Cell AssayMarie Wunsch, Richard Caspell, Stefanie Kuerten, et al.
Cells|February 3, 2015
ELISPOT Assays in 384-Well Format: Up to 30 Data Points with One Million CellsJodi Hanson, Srividya Sundararaman, Richard Caspell, et al.
Cells|December 8, 2017
A Positive Control for Detection of Functional CD4 T Cells in PBMC: The CPI PoolAnnemarie Schiller, Ting Zhang, Ruliang Li, et al.
Cells|January 23, 2015
ELISPOTs Produced by CD8 and CD4 Cells Follow Log Normal Size Distribution Permitting Objective CountingAlexey Y Karulin, Kinga Karacsony, Wenji Zhang, et al.
Viruses|August 11, 2015
Characterization of the HCMV-Specific CD4 T Cell Responses that Are Associated with Protective ImmunityMarie Wunsch, Wenji Zhang, Jodi Hanson, et al.
Cells|April 27, 2018
High-Throughput GLP-Capable Target Cell Visualization Assay for Measuring Cell-Mediated CytotoxicityAnna Welter, Srividya Sundararaman, Ruliang Li, et al.
Cells|January 14, 2015
High Reproducibility of ELISPOT Counts from Nine Different LaboratoriesSrividya Sundararaman, Alexey Y Karulin, Tameem Ansari, et al.
Pageof 1